CLINICAL_TRIALS
trial_result
· 2026-02-17
Clinical Trial Update: A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors [Phase 1]
Summary
Phase 1 study of JNJ-70218902 in participants with advanced solid tumors has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Neoplasms | Phase 1 | Status: COMPLETED